Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-25-022974
Filing Date
2025-08-25
Accepted
2025-08-25 21:33:15
Documents
2
Period of Report
2025-06-18

Document Format Files

Seq Description Document Type Size
1 form3-08262025_010811.html 3  
1 form3-08262025_010811.xml 3 6015
2 ex24-08262025_010811.htm EX-24 7128
  Complete submission text file 0001415889-25-022974.txt   14925
Mailing Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142
Business Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142 (857) 999-0075
KalVista Pharmaceuticals, Inc. (Issuer) CIK: 0001348911 (see all company filings)

EIN.: 200915291 | State of Incorp.: DE | Fiscal Year End: 0430
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O PRAXIS PRECISION MEDICINES, INC. ONE BROADWAY, 16TH FLOOR CAMBRIDGE MA 02142
Business Address
Sweeny Nicole (Reporting) CIK: 0001827505 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36830 | Film No.: 251252502